Quality Management
Wacker Biotech works in accordance with pharmaceutical GMP (Good Manufacturing Practice) to ensure the high quality required for the approval of clinical studies or market approval by the American FDA (Food and Drug Administration) or the European EMA (European Medicines Agency). The European production facilities are FDA and EMA certified.
Quality Assurance / Regulatory Affairs
Wacker Biotech holds biomanufacturing certificates from the relevant authorities for all sites, and follows the ICH Q7 guidelines for GMP-compliant production of active pharmaceutical ingredients (APIs) and Drug Product (DP). All European GMP production facilities are approved for commercial manufacturing by EMA, FDA and/or ANVISA.
With more than 1,200 released batches Wacker Biotech has a strong track record in supporting clients over the years with manufacturing of clinical trial material and approved products. Over the years, Wacker Biotech has successfully supported its customers in filing of INDs, IMPDs, DMFs, MAAs and BLAs. Upon request, Wacker Biotech will draft CMC related sections of your dossier/application.
In addition, the facility has been inspected and approved by several other international regulatory authorities, such as Korean MFDS, Brazilian ANVISA and Health Canada. The site in Amsterdam is licensed by the Dutch authorities for the production of biopharmaceuticals for clinical use and market supply.
In addition, the facility has been successfully inspected by America's FDA and Brazil's ANVISA. The site in Jena is licensed by the German authorities for the production of clinical and market supply of biopharmaceuticals.
In addition, the facility has been inspected and approved by several other international regulatory authorities, such as the FDA and Ministry of Health Turkey. The site in Halle is licensed by the German authorities for the production of clinical, and market supply of, biopharmaceuticals.
Quality Control
Our state-of-the-art microbiology, biochemistry and analytical chemistry labs offer certified analytical methods for biologics characterization for both drug substance and drug product. We offer validation of the analytical methods in accordance with current validation requirements as outlined in ICH Q2 guideline for validation of analytical procedures.
We follow GMP guidelines and meet the regulatory authorities’ requirements for the analytical determination of your product’s general characteristics, molecular structure determination, identity, activity, purity and safety, as well as the stability of the produced therapeutic proteins, vaccines, live microbial products and plasmid DNA.
In our biochemistry and microbiology labs, we carry out the analysis necessary to maintain our GMP standards for raw materials, water and environmental control.